Haleon plc
Market Cap
$41.73B
P/E Ratio
18.76
EPS
$0.50
Dividend Yield
2.89%
52-Week Range
$8.71 — $11.42
Volume
7.27M
Avg Volume
8.26M
Beta
0.33
Get alerted when HLN hits your target price.
Free — enter your email to get started
P/E (TTM)
18.76
Forward P/E
23.08
PEG Ratio
5.09
P/S (TTM)
3.94
P/B (TTM)
2.01
P/FCF
72.84
EV/EBITDA
59.98x
EV/Sales
—
ROE (TTM)
0.06%
ROA (TTM)
0.03%
ROIC
0.02%
Gross Margin
0.61%
Operating Margin
0.19%
Net Margin
0.15%
Debt/Equity
0.52
Current Ratio
0.92
EPS Growth (YoY)
+0.35%
Revenue Growth (YoY)
+0.00%
EPS Growth (3Y)
+0.04%
EPS Growth (5Y)
+0.22%
Sales Growth (3Y)
+0.06%
Sales Growth (5Y)
+0.06%
EPS Est (This Year)
$0.41
EPS Est (Next Year)
$0.44
Dividend Yield
—
Annual Dividend
$0.06
Payout Ratio
0.51%
Frequency
—
Ex-Dividend Date
2025-08-15
Cash/Share
$0.15
Buy
1 = Strong Buy, 5 = Strong Sell
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
4.51B
Float
4.49B
Free Float %
99.62%
RSI (14)
77.38
SMA 20
$10.47
SMA 50
$10.09
SMA 200
$9.81
ATR (14)
0.19
Volatility (Week)
0.01%
Volatility (Month)
0.01%
Pattern
—
1 Day
+1.09%
1 Week
+3.52%
1 Month
+13.99%
3 Months
+16.61%
6 Months
+16.49%
1 Year
—
YTD
+11.60%
All-Time High
$11.42
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
GB
Exchange
NYSE
IPO Date
2022-07-25
Employees
24561
CEO
Brian James McNamara
Index Membership
—
Website
https://www.haleon.com
Haleon plc (HLN) is a healthcare company in the drug manufacturers - specialty & generic industry listed on the NYSE. With a market capitalization of $41.73B, a P/E ratio of 18.76, and a dividend yield of 2.89%, HLN is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare HLN against other stocks using dozens of fundamental and technical filters.
Haleon plc (HLN) has a trailing twelve-month (TTM) P/E ratio of 18.76. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Haleon plc (HLN) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Haleon plc (HLN) has a market capitalization of $41.73 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Buy" rating on Haleon plc (HLN) with an average score of 2.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $10.20 implies 8.7% upside from the current price.
Haleon plc (HLN) has returned +11.60% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.